CA2165792A1 - Tetrazole derivatives - Google Patents

Tetrazole derivatives

Info

Publication number
CA2165792A1
CA2165792A1 CA002165792A CA2165792A CA2165792A1 CA 2165792 A1 CA2165792 A1 CA 2165792A1 CA 002165792 A CA002165792 A CA 002165792A CA 2165792 A CA2165792 A CA 2165792A CA 2165792 A1 CA2165792 A1 CA 2165792A1
Authority
CA
Canada
Prior art keywords
atom
compound
tetrazol
propyl
bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002165792A
Other languages
English (en)
French (fr)
Inventor
Masatoshi Hayashi
Masaya Kato
Yusuke Sakai
Kazuhiko Mitsui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Steel Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2165792A1 publication Critical patent/CA2165792A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CA002165792A 1993-06-29 1994-06-23 Tetrazole derivatives Abandoned CA2165792A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP15874193 1993-06-29
JP158745/1993 1993-06-29
JP158741/1993 1993-06-29
JP15874593 1993-06-29
JP13875694A JP3338913B2 (ja) 1993-06-29 1994-06-21 テトラゾール誘導体
JP138756/1994 1994-06-21

Publications (1)

Publication Number Publication Date
CA2165792A1 true CA2165792A1 (en) 1995-01-12

Family

ID=27317735

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002165792A Abandoned CA2165792A1 (en) 1993-06-29 1994-06-23 Tetrazole derivatives

Country Status (8)

Country Link
EP (1) EP0706522A1 (enExample)
JP (1) JP3338913B2 (enExample)
KR (1) KR960703405A (enExample)
AU (1) AU673754B2 (enExample)
CA (1) CA2165792A1 (enExample)
IL (1) IL110144A0 (enExample)
TW (1) TW281677B (enExample)
WO (1) WO1995001350A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3779349B2 (ja) * 1995-04-24 2006-05-24 興和株式会社 ピペリジン誘導体
EP0916668A4 (en) * 1996-07-29 2000-08-16 Banyu Pharma Co Ltd CHEMOKIN RECEPTOR ANTAGONISTS
ES2172436B1 (es) * 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
WO2003032912A2 (en) 2001-10-16 2003-04-24 Hypnion, Inc. Treatment of cns disorders using cns target modulators
US7355042B2 (en) 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US7189757B2 (en) 2001-10-16 2007-03-13 Hypnion, Inc. Treatment of sleep disorders using CNS target modulators
ES2201907B1 (es) 2002-05-29 2005-06-01 Almirall Prodesfarma, S.A. Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
AU2003296373A1 (en) * 2002-12-18 2004-07-29 Bayer Cropscience Ag N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
US7326721B2 (en) 2003-12-10 2008-02-05 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7411069B2 (en) 2003-12-10 2008-08-12 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7482460B2 (en) 2003-12-10 2009-01-27 Hypnion, Inc. Doxepin analogs and methods of use thereof
WO2005102335A2 (en) * 2004-04-23 2005-11-03 Hypnion, Inc. Methods of treating sleep disorders
US20080214570A1 (en) * 2005-08-08 2008-09-04 Astrazeneca Ab Therapeutic Agents
WO2010013805A1 (ja) * 2008-08-01 2010-02-04 日本臓器製薬株式会社 アミノプロピリデン誘導体
JP7040802B2 (ja) * 2017-06-30 2022-03-23 株式会社ニコン 光学装置を製造する方法及び対応するシステム
JP6991315B2 (ja) 2018-04-19 2022-01-12 国立大学法人東京農工大学 サルコペニアの予防剤及び治療剤
CN113880808B (zh) * 2020-07-03 2024-12-31 合肥医工医药股份有限公司 一类三唑类化合物、制备方法及其医药用途
EP4691466A1 (en) 2023-07-25 2026-02-11 The Eye Hospital of Wenzhou Medical University Use of ptgds inhibitor in preparation of drug for treating cataracts
CN117599052A (zh) * 2023-07-25 2024-02-27 温州医科大学附属眼视光医院 Ptgds的抑制剂在制备治疗白内障药物上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
JPH03246287A (ja) * 1990-02-22 1991-11-01 Hokuriku Seiyaku Co Ltd ピペラジン誘導体
FR2665160A1 (fr) * 1990-07-26 1992-01-31 Esteve Labor Dr Nouveaux derives de 1-diphenylmethylpiperazine, leur preparation et leur application en tant que medicaments.
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.

Also Published As

Publication number Publication date
AU673754B2 (en) 1996-11-21
JPH0770112A (ja) 1995-03-14
KR960703405A (ko) 1996-08-17
JP3338913B2 (ja) 2002-10-28
AU6983094A (en) 1995-01-24
IL110144A0 (en) 1994-10-07
TW281677B (enExample) 1996-07-21
EP0706522A1 (en) 1996-04-17
WO1995001350A1 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
CA2165792A1 (en) Tetrazole derivatives
EP0100200B1 (en) 2-substituted 4-amino-6,7-dimethoxyquinolines
DE3855501T2 (de) Chinolin-derivate als antagonisten von leukotrien d 4?
US5877187A (en) Benzimidazole derivatives with antihistaminic activity
DE602005002470T2 (de) 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung
US4680296A (en) Piperidine derivatives and pharmaceutical compositions containing them
CA2144669A1 (en) Biphenyl derivatives
WO1997013766A1 (en) Substituted heteroaromatic derivatives
DE2939292A1 (de) N-phenoxyalkylpiperidin-derivate, verfahrenn zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
CA2045453C (en) Condensed heterocyclic compound and psychopharmaceutical composition containing same
DD291323A5 (de) Verfahren zur herstellung von piperidinen
FR2465732A1 (fr) Nouveaux derives de carbostyrile, leur procede de preparation et leur application en therapeutique
US5432179A (en) Piperazine derivatives and pharmaceuticals containing the same
US5095022A (en) Piperidine derivatives and pharmaceutical compositions comprising the same
EP1210335B1 (de) Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
USRE34918E (en) Azaazulene compounds which are useful as antiallergic and antiinflammatory agents
AU600378B2 (en) Piperidine derivatives, their preparation and their application in therapy
EP0579059B1 (en) Pyridazinone derivatives and processes for preparing the same
US4766215A (en) Histamine H1 -receptor antagonists
EP0251141A1 (en) Piperazine compounds, process for preparing them, pharmaceutical composition and use
DE69805033T2 (de) Tetrazolderivate als LTD4 und H1 Antagonisten
DE69732551T2 (de) Flavon Derivative und deren enthaltende Arzneimittel
DE69013173T2 (de) Bisarylalkenderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzung, die sie enthalten.
JPH04234359A (ja) １−ジフェニルメチルピペラジンの新規誘導体、それらの製法、及びそれらの医薬用途
WO1992001686A1 (en) 1,4-disubstituted piperazines

Legal Events

Date Code Title Description
FZDE Discontinued